Form4insider filings, from the source

SEC Form 4 · accession 0001127602-16-044363

LEXICON PHARMACEUTICALS, INC. · LXRX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
James F Tessmer
Officer — VP, Finance & Accounting
Period of report
Feb 29, 2016
Accepted (ET)
Mar 2, 2016 · 8:43 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001062822

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Feb 29, 2016M965—A12,709D
Common StockF1Feb 29, 2016M857—A13,566D
Common StockF1Feb 29, 2016M1,339—A14,905D
Common StockF1Feb 29, 2016M2,667—A17,572D
Common StockFeb 29, 2016F1,626$9.07D15,946D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock Units (Phantom Stock)F1,F3—Feb 29, 2016M965D——Common Stock9650D
Restricted Stock Units (Phantom Stock)F1,F4—Feb 29, 2016M857D——Common Stock857857D
Restricted Stock Units (Phantom Stock)F1,F5—Feb 29, 2016M1,339D——Common Stock1,3392,679D
Restricted Stock Units (Phantom Stock)F1,F6—Feb 29, 2016M2,667D——Common Stock2,6678,004D

Explanation of responses